Application no. and date | 04797809.3 (espacenet) (Federated) (European Patent Register), 20041110 | Patent/reg. no. and date | DK/EP 1689737, 20080716 | Publication date | 20060816 | Priority no. and date | GB 0326407, 20031112 | EP pub. no. and date |
EP 1689737 20060816 | Effective date | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN, GB | Applicant ref. no. | P80828994DK00E | Inventor | ALVARO, Giuseppe,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT, DI FABIO, Romano,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT, GIOVANNINI, Riccardo,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT, PAIO, Alfredo,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT, TRANQUILLINI, Maria Elvira,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT, MATTIOLI, Lucia,
GlaxoSmithKline, Via Alessandro Fleming 2
I-37100 Verona, IT | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 25/00 (2006.01) , C07D 401/04 (2006.01) | Title | Beta-lactamer til behandling af sygdomme i CNS | Int. application no. | EP2004012772 | Int. publication no. | WO2005049600 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|